BRIAN SCHWARTZ

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

Cyclacel Pharmaceuticals, Inc.

Filing Date Source Excerpt
2022-04-26 Dr. Brian Schwartz ... Class 2 Director ... The Science and Technology Committee ... consists of Dr. Robert Spiegel (Chairman), Dr. Samuel L. Barker and Dr. Brian Schwartz ... Brian Schwartz, M.D. ... Total ($) 125,674
2023-11-14 Dr. Brian Schwartz(5) ... Includes options to purchase 132 shares of Common Stock...
2024-05-08 Dr. Brian Schwartz ... Class 2 Director; Interim Chief Medical Officer ... Science and Technology Committee ... consists of Dr. Robert J. Spiegel (Chairman), Dr. Samuel L. Barker, Dr. Kenneth M. Ferguson and Dr. Brian Schwartz

Source material: SEC submissions metadata and DEF 14A proxy filings from EDGAR. Last updated: 2026-05-04